Sodium-diuril-01 (Chlorothiazide Sodium For Injection Usp 1)
Chlorothiazide Sodium Injection, Powder, Lyophilized, For Solution
Product Images NDC 0517-1820
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Chlorothiazide Sodium (NDC 0517-1820). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by American Regent, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Sodium-diuril-02 (Chlorothiazide Sodium For Injection Usp 2)
Container (Chlorothiazide Sodium For Injection Usp 3)
This is a description of Chlorothiazide Sodium for injection. It is used as a medication to help eliminate excess water and salt from the body. It comes in the form of a single, sterile, freeze-dried vial that contains 500 mg of Chlorothiazide Sodium, along with Mannitol and Sodium Fycronde. The medication should be reconstituted with a minimum of 18 ml of sterile water for injection. The reconstituted solution should be used immediately as a single dose. Unused portions should be discarded. The medication should be stored at temperatures between 20°C and 25°C. The usual adult dosage should be determined by a healthcare professional.*
Carton (Chlorothiazide Sodium For Injection Usp 4)
Chlorothiazide Sodium For Injection Usp 5
This appears to be a product testing label with a LOT number, an expiration date of November 2020, a GTIN (Global Trade Item Number) of 00305171820014, and an SN (serial number) of 0. Without additional context, it is not possible to determine the specific product being tested.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
